leucine rich alpha-2-glycoprotein 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| positive regulation of endothelial cell proliferation |
|
|
| immune response |
|
|
| transforming growth factor beta receptor signaling pathway |
|
|
| response to bacterium |
|
|
| positive regulation of epithelial to mesenchymal transition |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| type II transforming growth factor beta receptor binding |
|
|
| type II transforming growth factor beta receptor binding |
|
|
| transforming growth factor beta receptor binding |
|
|
| protein binding |
|
|
| type I transforming growth factor beta receptor binding |
|
| InterPro |
|---|
| Leucine-rich repeat domain superfamily |
| Leucine-rich repeat, typical subtype |
| Leucine-rich repeat |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026